Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo

Hepatocellular carcinoma results in a high risk of second primary malignancies and has prominent morbidity and mortality. There is a lack of effective treatment and prognosis is poor. Therefore, effective drugs need to be discovered. Carrimycin is a 16-member macrolide antibiotic with anticancer act...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yong Jin, Hong Xiang Zuo, Ming Yue Li, Zhi Hong Zhang, Yue Xing, Jing Ying Wang, Juan Ma, Gao Li, Hongxin Piao, Puqing Gu, Xuejun Jin
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-11-01
Col·lecció:	Frontiers in Pharmacology
Matèries:	carrimycin monomeric isovalerylspiramycin I hepatocellular carcinoma anti-tumor in vitro in vivo
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fphar.2021.774231/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!